Clinical features of Chinese coronary heart disease patients with chronic Kidney disease

Renal Failure

Volumn 34, Issue 8, 2012, Pages 985-990

  Wang, Yong ^a   Zhao, Dongdong ^a   Xing, Yan ^a   Li, Jue ^a   Hu, Dayi ^a   Xu, Yawei ^a   Merriam, Philip A ^b   Ma, Yunsheng ^b  

^a TONGJI UNIVERSITY   (China)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Coronary disease; Kidney; Risk factors

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CHINESE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COMORBIDITY; CORONARY DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84865205904     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.706879     Document Type: Article

References (26)

1. Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular disease: Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746-2753.
2. Marques MD, Santos RD, Parga JR, et al. Relation between visceral fat and coronary artery disease evaluated by multidetector computed tomography. Atherosclerosis. 2010;209:481-486.
3. Liu J, Hong Y, D'Agostino Sr. RB, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA. 2004;291:2591-2599.
4. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
5. Han SS, Kim KW, Na KY, et al. Quality of life and mortality from a nephrologist's view: A prospective observational study. BMC Nephrol. 2009;10:39.
6. Eknoyan G, Lameire N, Barsoum R, et al. The burden of kidney disease: Improving global outcomes. Kidney Int. 2004;66:1310-1314.
7. Hou FF. Cardiovascular risk in Chinese patients with chronic kidney diseases: Where do we stand? Chin Med J (Engl). 2005;118:883-886.
8. Wang H, Zhang L, Lv J. Prevention of the progression of chronic kidney disease: Practice in China. Kidney Int. 2005;94(Suppl.): S63-S67.
9. Zhang L, Zuo L, Wang F, et al. Cardiovascular disease in early stages of chronic kidney disease in a Chinese population. J Am Soc Nephrol. 2006;17:2617-2621.
10. Holme I, Cater NB, Faergeman O, et al. Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease In End points Through Aggressive Lipid-lowering Trial (IDEAL). Ann Med. 2008;40:456-464.
11. Kiyosue A, Hirata Y, Ando J, et al. Relationship between renal dysfunction and severity of coronary artery disease in Japanese patients. Circ J. 2010;74:786-791.
12. Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937-2944.
13. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39 (2 Suppl. 1):S1-S266.
14. Brosius 3rd FC, Alpers CE, Bottinger EP, et al. Mouse models of diabetic nephropathy. J Am Soc Nephrol. 2009;20:2503-2512.
15. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
16. Yang JG, Li J, Lu C, et al. Chronic kidney disease, all-cause mortality and cardiovascular mortality among Chinese patients with established cardiovascular disease. J Atheroscler Thromb. 2010;17:395-401.
17. Zhang L, Zuo L, Wang F, et al. Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older. Mayo Clin Proc. 2007;82:822-827.
18. Cases Amenós A, González-Juanatey JR, Conthe Gutiérrez P, et al. Prevalence of chronic kidney disease in patients with or at a high risk of cardiovascular disease. Rev Esp Cardiol. 2010;63:225-228.
19. Farmer JA, Torre-Amione G. Atherosclerosis and inflammation. Curr Atheroscler Rep. 2002;4:92-98.
20. Ross R. Atherosclerosis: An inflammatory disease.NEngl JMed. 1999;340:115-126.
21. Ridker PM, Bassuk SS, Toth PP. C-reactive protein and risk of cardiovascular disease: Evidence and clinical application. Curr Atheroscler Rep. 2003;5:341-349.
22. Soinio M, Marniemi J, Laakso M, et al. High-sensitivity Creactive protein and coronary heart disease mortality in patients with type 2 diabetes: A 7-year follow-up study. Diabetes Care. 2006;29:329-333.
23. Clearfield MB. C-reactive protein: A new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc. 2005;105: 409-416.
24. Olivero JJ, Nguyen PT, Olivero JJ. Chronic kidney disease: A marker of cardiovascular disease. Methodist Debakey Cardiovasc J. 2009;5:24-29.
25. Poulter N. Global risk of cardiovascular disease. Heart. 2003;89 (Suppl. 2):ii2-ii5; discussion ii35-ii37.
26. Wu Z, Yao C, Zhao D, et al. Sino-MONICA project: A collaborative study on trends and determinants in cardiovascular diseases in China, Part I: Morbidity and mortality monitoring. Circulation. 2001;103:462-468.